Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Daiichi Sankyo’s
.
Show all posts
Showing posts with label
Daiichi Sankyo’s
.
Show all posts
Thursday, March 7, 2019
FDA Grants Priority Review for Daiichi Sankyo’s New Drug Application for CSF1R Inhibitor Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating Tumor
›
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a...
›
Home
View web version
